Growth differentiation factor 15 is increased in stable MS

OBJECTIVE: To assess whether serum concentrations of the anti-inflammatory cytokine growth differentiation factor 15 (GDF-15) differ in patients with highly active multiple sclerosis (MS) vs patients with stable MS and healthy controls (HCs). METHODS: GDF-15 concentrations were measured by ELISA in...

Descripción completa

Detalles Bibliográficos
Autores principales: Amstad, Andrea, Coray, Mali, Frick, Corina, Barro, Christian, Oechtering, Johanna, Amann, Michael, Wischhusen, Jörg, Kappos, Ludwig, Naegelin, Yvonne, Kuhle, Jens, Mehling, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051204/
https://www.ncbi.nlm.nih.gov/pubmed/32024796
http://dx.doi.org/10.1212/NXI.0000000000000675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051204/
https://www.ncbi.nlm.nih.gov/pubmed/32024796
http://dx.doi.org/10.1212/NXI.0000000000000675

Ejemplares similares